Highlights
1 patent
About
Hybrid Hydrogels for Orthopedics and Rheumatology
Chi2Gel is a development-stage company that intends to develop a hydrogel-based device to revitalize degenerated spinal discs. The companys proprietary hybrid hydrogel is currently in advanced preclinical development in the fields of orthopedics and rheumatology. Chi2Gels current development focus is on patients with painful knee osteoarthritis, for whom Chi2Knee will be indicated for intra-articular injection as a viscosupplement. Chi2Gels hydrogel will later be developed for lower back pain related to degenerative disc disease, in which Chi2Disc will be used in conjunction with a proprietary disc-restorative device.
Identity
| Name | Chi2gel |
|---|---|
| Slug | chi2gel |
| Type / kind | startup |
| Crunchbase ID | chi2gel |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6n6J0KDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, May 2019 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | South District |
| HQ city | Ofakim |
| HQ address | Bezalel Street 7, Ofakim, Israel |
Web & social
| https://www.linkedin.com/company/1450934 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymers
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProviders
Business models
B2BB2G
Tags
osteoarthritisorthopedicsdegenerative-diseasesmedical-devicespolymers
Funding
| Total raised | $658K |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}